JP2014512351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014512351A5 JP2014512351A5 JP2014501739A JP2014501739A JP2014512351A5 JP 2014512351 A5 JP2014512351 A5 JP 2014512351A5 JP 2014501739 A JP2014501739 A JP 2014501739A JP 2014501739 A JP2014501739 A JP 2014501739A JP 2014512351 A5 JP2014512351 A5 JP 2014512351A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- dose
- acid
- amount
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 24
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 8
- 239000003814 drug Substances 0.000 claims 8
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims 8
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims 7
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims 7
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims 7
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims 7
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims 7
- 235000020778 linoleic acid Nutrition 0.000 claims 7
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims 7
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 7
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 6
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims 6
- 235000010382 gamma-tocopherol Nutrition 0.000 claims 6
- 150000004671 saturated fatty acids Chemical class 0.000 claims 6
- 239000002478 γ-tocopherol Substances 0.000 claims 6
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 claims 6
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 5
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims 5
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims 5
- 229960002733 gamolenic acid Drugs 0.000 claims 5
- 229930003427 Vitamin E Natural products 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 4
- 235000019165 vitamin E Nutrition 0.000 claims 4
- 239000011709 vitamin E Substances 0.000 claims 4
- 229940046009 vitamin E Drugs 0.000 claims 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims 3
- 235000013734 beta-carotene Nutrition 0.000 claims 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims 3
- 239000011648 beta-carotene Substances 0.000 claims 3
- 229960002747 betacarotene Drugs 0.000 claims 3
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims 3
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 claims 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 2
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 claims 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 2
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 claims 2
- 235000019155 vitamin A Nutrition 0.000 claims 2
- 239000011719 vitamin A Substances 0.000 claims 2
- 229940045997 vitamin a Drugs 0.000 claims 2
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 claims 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 1
- ULNRTPCFRBIMKL-GHVJWSGMSA-N (e)-2-tetracosenoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCC\C=C\C(O)=O ULNRTPCFRBIMKL-GHVJWSGMSA-N 0.000 claims 1
- ATNNLHXCRAAGJS-QZQOTICOSA-N (e)-docos-2-enoic acid Chemical compound CCCCCCCCCCCCCCCCCCC\C=C\C(O)=O ATNNLHXCRAAGJS-QZQOTICOSA-N 0.000 claims 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 claims 1
- 206010061818 Disease progression Diseases 0.000 claims 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 claims 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 1
- 239000005642 Oleic acid Substances 0.000 claims 1
- 235000021314 Palmitic acid Nutrition 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- HQPCSDADVLFHHO-LTKCOYKYSA-N all-cis-8,11,14,17-icosatetraenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HQPCSDADVLFHHO-LTKCOYKYSA-N 0.000 claims 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000005750 disease progression Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims 1
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 claims 1
- 229940108623 eicosenoic acid Drugs 0.000 claims 1
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 claims 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 1
- 229960004488 linolenic acid Drugs 0.000 claims 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161469081P | 2011-03-29 | 2011-03-29 | |
| US61/469,081 | 2011-03-29 | ||
| PCT/IB2012/000824 WO2012131493A1 (en) | 2011-03-29 | 2012-03-28 | Compositions for the treatment of neurologic disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014512351A JP2014512351A (ja) | 2014-05-22 |
| JP2014512351A5 true JP2014512351A5 (OSRAM) | 2015-05-14 |
| JP6092843B2 JP6092843B2 (ja) | 2017-03-08 |
Family
ID=46275907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014501739A Expired - Fee Related JP6092843B2 (ja) | 2011-03-29 | 2012-03-28 | 神経障害の治療用組成物 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20120252888A1 (OSRAM) |
| EP (1) | EP2691086B1 (OSRAM) |
| JP (1) | JP6092843B2 (OSRAM) |
| CN (1) | CN104010634B (OSRAM) |
| AU (1) | AU2012235869B2 (OSRAM) |
| BR (1) | BR112013025088B1 (OSRAM) |
| CA (1) | CA2831506C (OSRAM) |
| CY (1) | CY1117828T1 (OSRAM) |
| DK (1) | DK2691086T3 (OSRAM) |
| EA (1) | EA025232B1 (OSRAM) |
| ES (1) | ES2585066T3 (OSRAM) |
| GE (1) | GEP201606568B (OSRAM) |
| HR (1) | HRP20160939T1 (OSRAM) |
| HU (1) | HUE028065T2 (OSRAM) |
| IL (1) | IL228541A (OSRAM) |
| MX (1) | MX2013011295A (OSRAM) |
| PL (1) | PL2691086T3 (OSRAM) |
| UA (1) | UA114706C2 (OSRAM) |
| WO (1) | WO2012131493A1 (OSRAM) |
| ZA (1) | ZA201307256B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10709680B2 (en) * | 2011-07-18 | 2020-07-14 | Physicians Recommended Nutriceuticals, Llc | Methods for treating dry eye |
| ITMI20130354A1 (it) * | 2013-03-08 | 2014-09-09 | Again Life Italia Srl | Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie. |
| EP3068386A1 (en) * | 2013-11-12 | 2016-09-21 | Abbott Laboratories | Uses of nutritional compositions including natural vitamin e, and polyunsaturated fatty acid |
| MX2016015791A (es) * | 2014-06-06 | 2017-05-30 | Marine Ingredients Llc | Composiciones de omega-3, formas de dosis, y metodos de uso. |
| KR20180004096A (ko) * | 2014-07-11 | 2018-01-10 | 매뉴 졸리 배다캐무리 | 최적화 된 영양 지방산 조성 |
| DE102015109352A1 (de) * | 2015-06-12 | 2016-12-15 | K. D. Pharma Bexbach Gmbh | Anwendung von Omega-3- und/oder Omega-6-Fettsäure(n) |
| AR102008A1 (es) * | 2015-09-24 | 2017-01-25 | Brix S R L | Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas |
| WO2017213490A1 (en) | 2016-06-10 | 2017-12-14 | N.V. Nutricia | Method for controlling neuroinflammation |
| JP2019534329A (ja) * | 2016-11-04 | 2019-11-28 | アイエムエムディー エスペー．ゾー．オー | 摂取および吸収された分子の知的送達 |
| CN109125311A (zh) * | 2018-06-26 | 2019-01-04 | 东南大学 | 预防或治疗阿尔茨海默症的药物组合物及其应用 |
| EP4288046A4 (en) * | 2021-02-08 | 2024-12-11 | Synaptogenix, Inc. | TREATMENT OF OPTIC NERVE INFECTION WITH PKC ACTIVATORS |
| WO2022170232A1 (en) * | 2021-02-08 | 2022-08-11 | Synaptogenix, Inc. | Treatment of multiple sclerosis using pkc activators |
| US12048681B2 (en) * | 2021-08-09 | 2024-07-30 | Kentucky Equine Research, Inc. | Compositions and methods for modulating equine fatty acid profiles |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601399D0 (en) * | 1986-01-21 | 1986-02-26 | Delta Iota Ltd | Information transmission/processing |
| GB8601915D0 (en) * | 1986-01-27 | 1986-03-05 | Efamol Ltd | Pharmaceutical compositions |
| GB8813766D0 (en) | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
| GB9001121D0 (en) * | 1990-01-18 | 1990-03-21 | Efamol Holdings | Efa compositions and therapy |
| PH31403A (en) * | 1991-03-01 | 1998-10-29 | Warner Lambert Co | Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same. |
| GB9111900D0 (en) * | 1991-06-03 | 1991-07-24 | Efamol Holdings | Fatty acid compositions |
| JP3283274B2 (ja) * | 1991-06-15 | 2002-05-20 | サントリー株式会社 | 新規組成物 |
| GB9506837D0 (en) * | 1995-04-03 | 1995-05-24 | Scotia Holdings Plc | Triglycerides |
| DE19757414A1 (de) * | 1997-12-23 | 1999-07-01 | Nutricia Nv | Fettmischung |
| US6048891A (en) * | 1998-12-17 | 2000-04-11 | Loma Linda University Medical Center | Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease |
| GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
| US6677321B1 (en) * | 1999-12-09 | 2004-01-13 | Bruce Levin | Methods and compositions for treatment of inflammatory disease |
| US7045683B2 (en) | 2001-05-04 | 2006-05-16 | Abbott Laboratories | Δ4-desaturase genes and uses thereof |
| CZ299784B6 (cs) * | 2001-05-30 | 2008-11-26 | Laxdale Limited | Lécivo obsahující EPA a ubichinon pro lécení non-Hodgkinova lymfomu, psychiatrických a neurologických chorob |
| EP1417211B1 (en) | 2001-07-27 | 2007-05-30 | Neptune Technologies & Bioressources Inc. | Natural phospholipids of marine origin containing flavonoids and polyunsaturated phospholipids and their uses |
| WO2003043570A2 (en) * | 2001-11-15 | 2003-05-30 | Galileo Laboratories, Inc. | Formulations and methods for treatment or amelioration of inflammatory conditions |
| US20050080109A1 (en) | 2003-10-09 | 2005-04-14 | Papas Andreas M. | Gamma-tocopherol and gamma-tocotrienol therapy for multiple sclerosis |
| EP3263101A1 (en) * | 2005-12-21 | 2018-01-03 | Brudy Technology, S.L. | Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage |
| US20090196862A1 (en) * | 2008-01-22 | 2009-08-06 | William Davis | High dosage Vitamin D |
| JP2010155799A (ja) * | 2008-12-26 | 2010-07-15 | Fujifilm Corp | 粉末組成物及びそれを含む食品 |
| JP5872453B2 (ja) * | 2009-04-17 | 2016-03-01 | ナタク ファルマ エセ．エレ． | フィタン酸含量が低く、ω−３脂肪酸に富む組成物 |
-
2012
- 2012-03-27 US US13/431,429 patent/US20120252888A1/en not_active Abandoned
- 2012-03-28 DK DK12727411.6T patent/DK2691086T3/en active
- 2012-03-28 BR BR112013025088-7A patent/BR112013025088B1/pt not_active IP Right Cessation
- 2012-03-28 HR HRP20160939TT patent/HRP20160939T1/hr unknown
- 2012-03-28 MX MX2013011295A patent/MX2013011295A/es not_active Application Discontinuation
- 2012-03-28 UA UAA201312638A patent/UA114706C2/uk unknown
- 2012-03-28 WO PCT/IB2012/000824 patent/WO2012131493A1/en not_active Ceased
- 2012-03-28 EP EP12727411.6A patent/EP2691086B1/en not_active Revoked
- 2012-03-28 EA EA201391407A patent/EA025232B1/ru not_active IP Right Cessation
- 2012-03-28 CN CN201280026514.3A patent/CN104010634B/zh not_active Expired - Fee Related
- 2012-03-28 GE GEAP201213272A patent/GEP201606568B/en unknown
- 2012-03-28 HU HUE12727411A patent/HUE028065T2/en unknown
- 2012-03-28 ES ES12727411.6T patent/ES2585066T3/es active Active
- 2012-03-28 JP JP2014501739A patent/JP6092843B2/ja not_active Expired - Fee Related
- 2012-03-28 AU AU2012235869A patent/AU2012235869B2/en not_active Ceased
- 2012-03-28 PL PL12727411.6T patent/PL2691086T3/pl unknown
- 2012-03-28 CA CA2831506A patent/CA2831506C/en not_active Expired - Fee Related
-
2013
- 2013-09-27 ZA ZA2013/07256A patent/ZA201307256B/en unknown
- 2013-09-29 IL IL228541A patent/IL228541A/en active IP Right Grant
-
2016
- 2016-07-26 CY CY20161100730T patent/CY1117828T1/el unknown
-
2019
- 2019-05-22 US US16/419,213 patent/US20190343774A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014512351A5 (OSRAM) | ||
| Calder | Fatty acids and inflammation: the cutting edge between food and pharma | |
| Devassy et al. | Omega-3 polyunsaturated fatty acids and oxylipins in neuroinflammation and management of Alzheimer disease | |
| HRP20160939T1 (hr) | Pripravci za liječenje neuroloških poremećaja | |
| JP2007504225A5 (OSRAM) | ||
| HRP20210309T1 (hr) | Postupci za smanjivanje rizika kardiovaskularnih slučajeva kod pojedinca na statinskoj terapiji uporabom etilestera eikosapentaenoične kiseline | |
| Kaur et al. | Essential fatty acids as functional components of foods-a review | |
| HRP20200065T1 (hr) | Upotreba etilnog estera ikozapentaenske kiseline u liječenju hipertrigliceridemije | |
| JP2020500193A5 (OSRAM) | ||
| Kuhnt et al. | Dietary Echium Oil Increases Long-Chain n–3 PUFAs, Including Docosapentaenoic Acid, in Blood Fractions and Alters Biochemical Markers for Cardiovascular Disease Independently of Age, Sex, and Metabolic Syndrome | |
| JP2015143248A5 (OSRAM) | ||
| JP2012516852A5 (OSRAM) | ||
| NZ631702A (en) | Production of long chain polyunsaturated fatty acids in plant cells | |
| NZ626699A (en) | Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form | |
| PE20170253A1 (es) | Lipido que comprende acidos grasos poliinsaturados de cadena larga | |
| MX356427B (es) | Emulsion que contiene hormona. | |
| BRPI0418921A (pt) | uso de ácidos graxos poliinsaturados, composição nutricional, e, uso de uma composição | |
| JP2011529503A5 (OSRAM) | ||
| RU2019110681A (ru) | Фармацевтическая композиция | |
| JP6819957B2 (ja) | １０−ヒドロキシ−２−デセン酸を含む方法及び組成物 | |
| UA89207C2 (ru) | Применение длинноцепочечных полиненасыщенных жирных кислот для получения жидкой питательной смеси для кормления детей | |
| JP2007518764A5 (OSRAM) | ||
| WO2006078457A3 (en) | Use of resolvins to treat gastrointestinal diseases | |
| JP2006503031A5 (OSRAM) | ||
| HRP20191963T1 (hr) | Smjesa masnih kiselina za primjenu u liječenju upalnih patologija |